We only have this paper's title and publication details.
Read it at the sourceEvaluates tofersen for treating pseudo-progression in SOD1-associated ALS, suggesting new therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Sadaghiani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: